JAC Advance Access originally published online on May 29, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 140-141
© 2003 The British Society for Antimicrobial Chemotherapy
Correspondence |
Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997–2001)
1 Laboratório Especial de Microbiologia Clínica, Disciplina de Doenças Infecciosas e Parasitárias, Universidade Federal de São Paulo, Rua Leandro Dupret, 188, São Paulo, SP-04025.010, Brazil; 2 The Jones Group/JMI Laboratories, North Liberty, IA, USA
Keywords: Pseudomonas aeruginosa, carbapenem resistance, Latin America, SENTRY Antimicrobial Surveillance Program
| The first 10% of the full text of this article appears below. |
Sir,
Recent studies have focused on the decreased susceptibility of Pseudomonas aeruginosa to currently used anti-pseudomonal agents, including ß-lactams, aminoglycosides and fluoroquinolones.1,2 The carbapenems imipenem and meropenem are usually active against multidrug-resistant isolates of P. aeruginosa; however, resistance to these compounds has also become a growing therapeutic problem.2 The SENTRY Antimicrobial Surveillance Program is a global resistance monitoring system designed to assess antimicrobial resistance trends worldwide. The present study was conducted to determine the variation in susceptibility rates of P. aeruginosa in participant Latin American medical centres to selected antimicrobial agents for
Acknowledgements
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E. Skindersoe, M. Alhede, R. Phipps, L. Yang, P. O. Jensen, T. B. Rasmussen, T. Bjarnsholt, T. Tolker-Nielsen, N. Hoiby, and M. Givskov Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3648 - 3663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, M. A. Toleman, P. M. Bennett, R. N. Jones, and T. R. Walsh Complete Sequence of p07-406, a 24,179-Base-Pair Plasmid Harboring the blaVIM-7 Metallo-{beta}-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3099 - 3105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Reinert, D. E. Low, F. Rossi, X. Zhang, C. Wattal, and M. J. Dowzicky Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline J. Antimicrob. Chemother., November 1, 2007; 60(5): 1018 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Horianopoulou, N. J. Legakis, M. Kanellopoulou, S. Lambropoulos, A. Tsakris, and M. E. Falagas Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit. J. Med. Microbiol., October 1, 2006; 55(Pt 10): 1435 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Zavascki, P. B. Gaspareto, A. F. Martins, A. L. Goncalves, and A. L. Barth Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil J. Antimicrob. Chemother., December 1, 2005; 56(6): 1148 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Nouer, M. Nucci, M. P. de-Oliveira, F. L. P. C. Pellegrino, and B. M. Moreira Risk Factors for Acquisition of Multidrug-Resistant Pseudomonas aeruginosa Producing SPM Metallo-{beta}-Lactamase Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3663 - 3667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Walsh, M. A. Toleman, L. Poirel, and P. Nordmann Metallo-{beta}-Lactamases: the Quiet before the Storm? Clin. Microbiol. Rev., April 1, 2005; 18(2): 306 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Poole Aminoglycoside Resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother., February 1, 2005; 49(2): 479 - 487. [Full Text] [PDF]
|
|
|
|
|
|
R. E. Mendes, M. A. Toleman, J. Ribeiro, H. S. Sader, R. N. Jones, and T. R. Walsh Integron Carrying a Novel Metallo-{beta}-Lactamase Gene, blaIMP-16, and a Fused Form of Aminoglycoside-Resistant Gene aac(6')-30/aac(6')-Ib': Report from the SENTRY Antimicrobial Surveillance Program Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4693 - 4702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Pucci, J. J. Bronson, J. F. Barrett, K. L. DenBleyker, L. F. Discotto, J. C. Fung-Tomc, and Y. Ueda Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3697 - 3701. [Abstract] [Full Text] [PDF]
|
|